WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...

Biocon stock ended 4% higher at Rs 317.60 on Friday against the previous close of Rs 305.20 on BSE. The stock touched an ...

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received ...

The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets ...

Biocon posted a net profit of Rs 659.7 crore, nearly three times higher than Rs 101.4 crore posted in the corresponding ...

In the last one year, shares of Biocon zoomed up to 17 per cent, while on a year-to-date basis it cracked over 13 per cent.

China - Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations. Explore the key provisions of China’s Anti-Monopoly Guidelines for the Pharmaceutical Sector, ...

TCS, Adani Energy Solutions, Tata Steel, BPFC, BHEL, Glenmark Pharma, Sun Pharma, Biocon, Bharti Hexacom, Bansal Wire, Taj ...

Trump is pushing for tariffs on pharmaceutical imports, citing concerns over the US’s dependency on foreign production, ...

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...

The healthcare IT market is expected to grow at a CAGR of 16% from 2025 to 2030, driven by several key factors. These include ...

Kenya’s healthcare system has long faced challenges such as limited access to quality medical services, understaffed ...